Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
triglyceride/otok
Веза се чува у привремену меморију
Страна 1 од 315 резултати
Primary Intestinal Lymphangiectasia Manifested as Unusual Edemas and Effusions: A Case Report.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Primary intestinal lymphangiectasia (PIL) is a rare disorder of unknown etiology characterized by diffuse or localized dilation and eventual rupture of the enteric lymphatic vessels in mucosa, submucosa, and/or subserosa. Lymph, rich in all kinds of proteins and lymphocytes, leaks into the
The pathogenesis of pulmonary edema in acute pancreatitis.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Acute pulmonary edema appeared 3 or more days after the onset of acute pancreatitis in 7 patients, an approximate incidence of 8%. The severity of pancreatitis in these patients was characterized by massive requirements for intravenous colloid and by marked hypocalcemia. In addition, at least 5 of
Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
We sought to evaluate the effects of muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor (PPAR) activator within the new glitazar class, on hyperglycemia and lipid abnormalities.
METHODS
A double-blind, randomized, controlled trial was performed in 1,159 patients
Antenatal treatment of chylothorax and cystic hygroma with OK-432 in nonimmune hydrops fetalis.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To present our experience of using OK-432 in treating fetal cystic hygroma and chylothorax complicated with nonimmune hydrops fetalis.
METHODS
OK-432 (Picibanil) was injected into the fetal pleural cavity or fetal cystic hygroma.
RESULTS
Patient 1: A 23-year-old, gravida 2, para 1, was
Modulation of pulmonary vascular resistance and edema formation by short-term infusion of a 10% fish oil emulsion.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
The aim of this study was to investigate whether the pulmonary response to inflammatory stimulation, resulting in increased vascular resistance and permeability, could be attenuated by short-term infusion of triglycerides containing omega-3 fatty acids. With the concept of altering the
Diabetic retinopathy with or without clinically significant macular edema: The influencing factors.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Diabetic retinopathy is the commonest micro vascular complication in patients with diabetes and remains a leading cause of blindness in people of working age group.
OBJECTIVE
to determine the prevalence of clinically significant macular edema (CSME) and the influence of systemic risk
Impact of estimated glomerular filtration rate on diabetic macular edema.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
Diabetic macular edema (DME) is a major cause of visual impairment in patients with diabetes and is influenced by various systemic factors. This study evaluates the effect of renal status on DME using estimated glomerular filtration rate (eGFR) as a study marker.
METHODS
This was a
Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To determine the incidence of diabetic retinopathy (DR) progression after phacoemulsification in patients with type II diabetes.
METHODS
Service of Ophthalmology, University of Sant Joan, Barcelona, Spain.
METHODS
This prospective study evaluated 132 patients with diabetes mellitus who had
Serum lipid profile in diabetic macular edema.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To evaluate the correlation of lipid profile and clinical presentation of macular edema in Type 2 diabetes mellitus (DM) patients.
METHODS
The study included 20 patients with chronic diabetic macular edema and plaque-like hard exudates (Group 1), 20 patients with diabetic macular edema
Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To determine the risk factors of clinically significant macular edema (CSME) in patients with non-proliferative diabetic retinopathy (NPDR) in a multi-ethnics Malaysian population.
METHODS
We performed a case control study in which 150 patients with bilateral NPDR and CSME in either eye
Primary intestinal lymphangiectasia diagnosed by double-balloon enteroscopy and treated by medium-chain triglycerides: a case report.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Primary intestinal lymphangiectasia is a disorder characterized by exudative enteropathy resulting from morphologic abnormalities of the intestinal lymphatics. Intestinal lymphangiectasia can be primary or secondary, so the diagnosis of primary intestinal lymphangiectasia must first
[Protein-losing enteropathy with systemic lupus erythematosus effectively treated with octreotide and medium chain triglyceride diet: A case report].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
In January 2009, a 62-year-old man presented with diarrhea, leg edema, and thrombopenia and was admitted to our hospital. The past medical history revealed Sjögren's syndrome and autoimmune hepatitis for which he had been administered prednisolone. On admission, a laboratory examination revealed
Influence of serum lipid fractions on the course of diabetic macular edema after photocoagulation.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The influence of serum lipid fractions [triglyceride, cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol] on the visual outcome after central laser photocoagulation of 39 patients (65 eyes) with clinically significant macular edema was investigated in
MBX-102/JNJ39659100, a novel non-TZD selective partial PPAR-γ agonist lowers triglyceride independently of PPAR-α activation.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
MBX-102/JNJ-39659100 (MBX-102) is a selective, partial PPAR-γ agonist that lowers glucose in the absence of some of the side effects, such as weight gain and edema, that are observed with the TZDs. Interestingly MBX-102 also displays pronounced triglyceride lowering in preclinical rodent models and
Efficiency of fenofibrate in facilitating the reduction of central macular thickness in diabetic macular edema.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The purpose of this study is to study the benefit of addition of oral fenofibrate to the current regimen of diabetic macular edema (DME) management and quantify its effect on macular thickness and visual function in DME.
Fifty-three eyes of 50 patients were randomized into treatment (Group A) (oral
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
